ICCC
HEALTHCAREImmucell Corp
$8.66-0.23 (-2.59%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving ICCC Today?
No stock-specific AI insight has been generated for ICCC yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$4.52$9.08
$8.66
Fundamentals
Market Cap$78M
P/E Ratio—
EPS$-0.12
Dividend Yield—
Dividend / Share—
ROE-0.0%
Profit Margin-0.0%
Debt / Equity—
Trading
Volume54K
Avg Volume (10D)—
Shares Outstanding9.0M
ICCC News
20 articles- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026Yahoo Finance·May 7, 2026
- The Zacks Analyst Blog The Goldman Sachs, NextEra, Shopify, Landmark and ImmuCellYahoo Finance·Apr 22, 2026
- Top Stock Reports for Goldman Sachs, NextEra Energy & ShopifyYahoo Finance·Apr 21, 2026
- ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent DirectorsYahoo Finance·Apr 13, 2026
- ImmuCell Announces a 28.4% Increase in Product Sales in Q1 of 2026, based on Preliminary, Unaudited Sales ResultsYahoo Finance·Apr 8, 2026
- ImmuCell Appoints Former Elanco Animal Health Board Member Kathy Turner to BoardYahoo Finance·Mar 18, 2026
- ImmuCell Corp (ICCC) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst ChallengesYahoo Finance·Mar 7, 2026
- ImmuCell 2025 Net Loss Narrows Y/Y as Sales & Margins ImproveYahoo Finance·Mar 6, 2026
- ImmuCell Q4 Earnings Call HighlightsMarketbeat·Mar 6, 2026
- ImmuCell Corporation Q4 2025 Earnings Call SummaryMoby·Mar 5, 2026
- ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2025Yahoo Finance·Mar 4, 2026
- ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025Yahoo Finance·Feb 18, 2026
- Niche Focus & Regulation Shape the Future of Healthcare FirmsYahoo Finance·Jan 15, 2026
- Those who invested in ImmuCell (NASDAQ:ICCC) a year ago are up 25%Yahoo Finance·Jan 12, 2026
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025Yahoo Finance·Jan 8, 2026
- ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in FocusYahoo Finance·Jan 7, 2026
- Top Stock Reports for AbbVie, Coca-Cola & ChevronYahoo Finance·Dec 24, 2025
- ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®Yahoo Finance·Dec 24, 2025
- ImmuCell's Two-Product Edge in Cattle Health Fuels GrowthYahoo Finance·Dec 4, 2025
- ImmuCell Corp (ICCC) Q3 2025 Earnings Call Highlights: Navigating Challenges with Strategic ...Yahoo Finance·Nov 25, 2025
All 20 articles loaded
Price Data
Open$8.73
Previous Close$8.89
Day High$8.99
Day Low$8.60
52 Week High$9.08
52 Week Low$4.52
52-Week Range
$4.52$9.08
$8.66
Fundamentals
Market Cap$78M
P/E Ratio—
EPS$-0.12
Dividend Yield—
Dividend / Share—
ROE-0.0%
Profit Margin-0.0%
Debt / Equity—
Trading
Volume54K
Avg Volume (10D)—
Shares Outstanding9.0M
About Immucell Corp
ImmuCell Corporation, an animal health company, develops, manufactures and markets products that improve the health and productivity of dairy and beef cattle in the United States and internationally. The company is headquartered in Portland, Maine.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—